Prologue Medicines
MA - BostonBiotechnology
Focus: Prologue Medicines is a Boston-based viral-derived biologics company founded in 2000, operating as a public biotech firm with 51-200 employees focused on infectious diseases, neurology, gastroenterology, oncology, and ophthalmology.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
85+40 this month
Hot — 71 jobs added in 30d
Net +40 (71 new, 31 removed). Aggressive expansion phase.
Should You Work at Prologue Medicines?
AI assessmentPrologue is a specialized mid-cap biotech with strong R&D hiring signals, but opaque pipeline and financial data present material career-planning uncertainty.
Why Work Here
- Active hiring across 75 open positions, with R&D leading at 24 roles—signal of ongoing research investment and pipeline advancement.
- Specialized focus on viral-derived biologics across five therapeutic areas provides deep technical expertise and broad disease relevance.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Prologue Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.